Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM452RF)

Drug Name
RG7880 Drug Info
Indication
Disease Entry ICD 11 Status REF
Diabetic foot ulcer BD54 Phase 2 [1]
Ulcerative colitis DD71 Phase 1 [2]
Cross-matching ID
TTD Drug ID
DM452RF

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Interleukin-22 (IL22)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fezakinumab DMJX2P4 Psoriasis vulgaris EA90 Phase 2 [4]
F-652 DM9201K Graft-versus-host disease 4B24 Phase 2 [5]
ILV-095 DMQ01MP Psoriasis vulgaris EA90 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-22 (IL22) TTLDX4N IL22_HUMAN Modulator [3]

References

1 Clinical pipeline report, company report or official report of Roche.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Emerging Therapies for the Treatment of Psoriasis. Dermatol Ther (Heidelb) 2012 December; 2(1): 16.
5 An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology. 2020 Aug;72(2):441-453.